FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Drug Test Anal / Long-term monitoring of IOX4 in horse hair and its longitudi...
Drug testing and analysis2022; 14(7); 1244-1254; doi: 10.1002/dta.3247

Long-term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometry for the purpose of doping control.

Abstract: IOX4, a hypoxia-inducible factor stabilizer, is classified as a banned substance for horses in both horse racing and equestrian sports. We recently reported the pharmacokinetic profiles of IOX4 in horse plasma and urine and also identified potential monitoring targets for the doping control purpose. In this study, a long-term longitudinal analysis of IOX4 in horse hair after a nasoesophageal administration of IOX4 (500 mg/day for 3 days) to three thoroughbred mares is presented for the first time for controlling the abuse/misuse of IOX4. Six bunches of mane hair were collected at 0 (pre), 1, 2, 3, and 6 month(s) postadministration. Our results showed that the presence of IOX4 was identified in all postadministration horse hair samples, but no metabolite could be detected. The detection window for IOX4 could achieve up to 6-month postadministration (last sampling point) by monitoring IOX4 in hair. In order to evaluate the longitudinal distribution of IOX4 over 6 months, a validated quantification method of IOX4 in hair was developed for the analysis of the postadministration samples. Segmental analysis of 2-cm cut hair across the entire length of postadministration hair showed that IOX4 could be quantified up to the level of 1.84 pg/mg. In addition, it was found that the movement of the incorporated IOX4 band in the hair shaft over 6 months varied among the three horses due to individual variation and a significant diffusion of IOX4 band up to 10 cm width was also observed in the 6-month postadministration hair samples.
© 2022 John Wiley & Sons, Ltd.
Get Full Text
Publication Date: 2022-03-07 PubMed ID: 35195358DOI: 10.1002/dta.3247Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study is about the monitoring of a banned substance called IOX4 in horse hair over a six-month period using high-resolution mass spectrometry. This substance is forbidden in horse racing and equestrian sports. The researchers were able to detect IOX4 in horse hair samples up to six months after its administration and found that its detection was possible without identifying any metabolites.

Research Objectives and Methodology

  • The study aimed to track the presence and distribution of IOX4, a hypoxia-inducible factor stabilizer, in the hair of horses over a period of six months. This substance, which can potentially be abused or misused in horse racing and equestrian sports, is prohibited.
  • Three thoroughbred mares were administrated IOX4 nasoesophageally at a dose of 500 mg per day for three days. Six bunches of mane hair were collected from each horse at specific intervals — before administration, and at 1, 2, 3 and 6 months post-administration.
  • The research team used liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometry to gauge the presence of IOX4 and its metabolites in the hair samples.

Findings

  • IOX4 was detected in all hair samples taken after the administration of the substance, however, no metabolites were identified.
  • The ability to detect IOX4 continued up to six months (the last sampling point). This indicates that IOX4 could potentially be long-term tracking marker for doping in horses.
  • To evaluate the distribution of IOX4 over the six months, the researchers developed a quantification method to monitor IOX4 in hair. Segmental analysis of 2-cm long hair strands demonstrated that IOX4 could be quantified up to the level of 1.84 pg/mg.
  • Note was made of the fact that the movement of the incorporated IOX4 band in the hair varied among the individual horses. A significant diffusion of IOX4 band up to 10 cm width was observable in the hair samples six months after administration.

Conclusion

  • This research demonstrated a viable method for the long-term monitoring of banned substances in equestrian sports, specifically focusing on the detection of IOX4 in horse hair. The findings may contribute to more effective measures for doping control in horse racing and other equestrian sports.

Cite This Article

APA
Ishii H, Shibuya M, So YM, Wong JKY, Ho ENM, Kusano K, Sone Y, Kamiya T, Wakuno A, Ito H, Miyata K, Yamada M, Leung GN. (2022). Long-term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometry for the purpose of doping control. Drug Test Anal, 14(7), 1244-1254. https://doi.org/10.1002/dta.3247

Publication

Drug testing and analysis
ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 14
Issue: 7
Pages: 1244-1254

Researcher Affiliations

Ishii, Hideaki
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
  • Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, Japan.
Shibuya, Mariko
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
So, Yat-Ming
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin, N.T., Hong Kong, China.
Wong, Jenny K Y
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin, N.T., Hong Kong, China.
Ho, Emmie N M
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin, N.T., Hong Kong, China.
Kusano, Kanichi
  • Veterinarian Section ∣ Equine Department, Japan Racing Association, Minato-ku, Tokyo, Japan.
Sone, Yu
  • Veterinarian Section ∣ Equine Department, Japan Racing Association, Minato-ku, Tokyo, Japan.
Kamiya, Takahiro
  • Equine Veterinary Clinic ∣ Horse Racing School, Japan Racing Association, Shiroi, Chiba, Japan.
Wakuno, Ai
  • Equine Veterinary Clinic ∣ Horse Racing School, Japan Racing Association, Shiroi, Chiba, Japan.
Ito, Hideki
  • Equine Veterinary Clinic ∣ Horse Racing School, Japan Racing Association, Shiroi, Chiba, Japan.
Miyata, Kenji
  • JRA Equestrian Park Utsunomiya Office, Japan Racing Association, Utsunomiya, Tochigi, Japan.
Yamada, Masayuki
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Leung, Gary Ngai-Wa
  • Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.

MeSH Terms

  • Animals
  • Chromatography, Liquid / methods
  • Doping in Sports / prevention & control
  • Female
  • Hair / chemistry
  • Horses
  • Spectrometry, Mass, Electrospray Ionization
  • Substance Abuse Detection / methods
  • Tandem Mass Spectrometry / methods

Grant Funding

  • 2021 / Japan Racing Association (JRA)

References

This article includes 60 references
  1. European Patent Office. Substituted dihydropyrazolones for treating cardiovascular and haematological diseases. .
  2. Figg WD Jr, McDonough MA, Chowdhury R. Structural basis of prolyl hydroxylase domain inhibition by molidustat. ChemMedChem 2021;16(13):2082-2088.
  3. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 2002;296(5574):1886-1889.
  4. Muchnik E, Kaplan J. HIF prolyl hydroxylase inhibitors for anemia. Expert Opin Investig Drugs 2011;20(5):645-656.
  5. Yan L, Colandrea VJ, Hale JJ. Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: Small molecule-based therapeutics for anemia. Expert Opin Ther Pat 2010;20(9):1219-1245.
  6. Bunn HF. New agents that stimulate erythropoiesis. Blood 2007;109(3):868-873.
  7. Chan MC, Atasoylu O, Hodson E. Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain. PLoS One 2015;10(7):1-17, e0132004.
  8. Beuck S, Schänzer W, Thevis M. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. Drug Test Anal 2012;4(11):830-845.
  9. Joharapurkar AA, Pandya VB, Patel VJ, Desai RC, Jain MR. Prolyl hydroxylase inhibitors: A breakthrough in the therapy of anemia associated with chronic diseases. J Med Chem 2018;61(16):6964-6982.
  10. Elvert G, Kappel A, Heidenreich R. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 2003;278(9):7520-7530.
  11. Semenza GL. A compendium of proteins that interact with HIF-1α. Exp Cell Res 2017;356(2):128-135.
  12. Chan MC, Ilott NE, Schödel J. Tuning the transcriptional response to hypoxia by inhibiting hypoxia-inducible factor (HIF) prolyl and asparaginyl hydroxylases. J Biol Chem 2016;291(39):20661-20673.
  13. International Federation of Horseracing Authorities. International agreement on breeding, racing and wagering and appendixes (January 2021). .
  14. Fédération Équestre Internationale. 2021 Equine Prohibited Substances List. .
  15. Philip M, Mathew B, Karatt TK, Perwad Z, Subhahar MB, Karakka Kal AK. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control. Drug Test Anal 2021;13(4):794-816.
  16. Ishii H, Shibuya M, So YM. Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometer for the purpose of doping control. Drug Test Anal 2021;14(2):1-19.
  17. Whittem T, Davis C, Beresford GD, Gourdie T. Detection of morphine in mane hair of horses. Aust Vet J 1998;76(6):426-427.
  18. Popot MA, Boyer S, Maciejewski P, Garcia P, Dehennin L, Bonnaire Y. Approaches to the detection of drugs in horse hair. In: Proceedings of the 13th International Conference of Racing Analysts and Veterinarians Cambridge, UK, 2000. Newmarket, UK: R & W Publications (Newmarket) Limited; 2001:115-120.
  19. Schlupp A, Anielski P, Thieme D, Müller RK, Meyer H, Ellendorff F. The beta-agonist clenbuterol in mane and tail hair of horses. Equine Vet J 2004;36(2):118-122.
  20. Moeller BC, Clifford A, Emery RT, Alarcio G, Favro G, Arthur RM. Detection and confirmation of zilpaterol in equine hair using liquid chromatography-mass spectrometry. Drug Test Anal 2022;14(1):31-38.
  21. Popot MA, Stojiljkovic N, Garcia P, Richard CA, Bonnaire Y, Tabet JC. Additional studies on the detection of drugs in horse hair samples. In: Proceedings of the 14th International Conference of Racing Analysts and Veterinarians Orlando, Florida, USA, 2002. Newmarket, UK: R & W Publications (Newmarket) Limited; 2003:224-233.
  22. Boyer S, Garcia P, Popot MA, Steiner V, Lesieur M. Detection of testosterone propionate administration in horse hair samples. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852(1-2):684-688.
  23. Anielski P, Thieme D, Schlupp A, Grosse J, Ellendorff F, Mueller RK. Detection of testosterone, nandrolone and precursors in horse hair. Anal Bioanal Chem 2005;383(6):903-908.
  24. Anielski P. Hair analysis of anabolic steroids in connection with doping control-results from horse samples. J Mass Spectrom 2008;43(7):1001-1008.
  25. Gray B, Pearce C, Lister S, Viljanto M, Brown P, Maynard S. Can hair be used as an alternative sample matrix for routine drug screening?. In: Soma LR, Uboh CE, Hill WT, eds. Proceedings of the 19th International Conference of Racing Analysts and Veterinarians Philadelphia, Pennsylvania, USA. Vol. 85; 2012.
  26. Gray B, Pearce C, Maynard S. Anabolic steroid ester administration studies: Comparison of results from plasma, urine and hair. In: Soma LR, Uboh CE, Hill WT, eds. Proceedings of the 19th International Conference of Racing Analysts and Veterinarians Philadelphia, Pennsylvania, USA. Vol. 398; 2012.
  27. Gray BP, Viljanto M, Bright J, Pearce C, Maynard S. Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds. Anal Chim Acta 2013;787:163-172.
  28. Ishii H, Shibuya M, Leung GN. Detection and longitudinal distribution of GW1516 and its metabolites in equine hair for doping control using liquid chromatography/high-resolution mass spectrometry. Rapid Commun Mass Spectrom 2021;35(8):1-9, e9050.
  29. Cutler C, Viljanto M, Hincks P, Habershon-Butcher J, Muir T, Biddle S. Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administration. Drug Test Anal 2020;12(2):247-260.
  30. Cutler C, Viljanto M, Taylor P. Equine metabolism of the selective androgen receptor modulator AC-262536 in vitro and in urine, plasma and hair following oral administration. Drug Test Anal 2021;13(2):369-385.
  31. Dunnett M, Tracey S, Warboys K, Lees P. Drug deposition in equine anagen and telogen hair. In: Proceedings of the 15th International Conference of Racing Analysts and Veterinarians Dubai, United Arab Emirates, 2004. Newmarket, UK: R & W Publications; 2005;502-508.
  32. Dunnett M. The diagnostic potential of equine hair: A comparative review of hair analysis for assessing nutritional status, environmental poisoning, and drug use and abuse. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.579.9724&rep=rep1&type=pdf. Accessed November 10, 2020.
  33. Dunnett M, Lees P. Hair analysis as a novel investigative tool for the detection of historical drug use/misuse in the horse: A pilot study. Equine Vet J 2004;36(2):113-117.
  34. Dunnett M, Richardson DW, Lees P. Detection of enrofloxacin and its metabolite ciprofloxacin in equine hair. Res Vet Sci 2004;77(2):143-151.
  35. Madry MM, Spycher BS, Kupper J. Long-term monitoring of opioid, sedative and anti-inflammatory drugs in horse hair using a selective and sensitive LC-MS/MS procedure. BMC Vet Res 2016;12(84):1-10.
  36. Kwok KY, Choi TLS, Kwok WH, Wong JKY, Wan TSM. Detection of anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry. J Chromatogr A 2017;1493:76-86.
  37. Choi TLS, Kwok KY, Kwok WH, Tsoi YYK, Wong JKY, Wan TSM. Detection of seventy-two anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry in multiplexed targeted MS2 mode and gas chromatography-tandem mass spectrometry. J Chromatogr A 2018;1566:51-63.
  38. Wong JKY, Choi TLS, Kwok KY, Lei ENY, Wan TSM. Doping control analysis of 121 prohibited substances in equine hair by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2018;158:189-203.
  39. Gray B, Viljanto M, Menzies E, Vanhaecke L. Detection of prohibited substances in equine hair by ultra-high performance liquid chromatography-triple quadrupole mass spectrometry-Application to doping control samples. Drug Test Anal 2018;10(7):1050-1060.
  40. Welch MJ, Sniegoski LT, Allgood CC, Habram M. Hair analysis for drugs of abuse: evaluation of analytical methods, environmental issues, and development of reference materials. J Anal Toxicol 1993;17(7):389-398.
  41. Welch MJ, Sniegoski LT, Tai S. Two new standard reference materials for the determination of drugs of abuse in human hair. Anal Bioanal Chem 2003;376(8):1205-1211.
  42. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 2006;370(1-2):17-49.
  43. Kuwayama K, Miyaguchi H, Iwata YT. Three-step drug extraction from a single sub-millimeter segment of hair and nail to determine the exact day of drug intake. Anal Chim Acta 2016;948:40-47.
  44. Kintz P, Ameline A, Gheddar L, Raul JS. Testing for GW501516 (cardarine) in human hair using LC/MS-MS and confirmation by LC/HRMS. Drug Test Anal 2020;12(7):980-986.
  45. Kintz P, Gheddar L, Raul JS. LC/MS-MS and confirmation by LC/HRMS hair tests to evidence use of tizanidine by racing cyclists. Drug Test Anal 2021;14(1):3164-3161.
  46. Shima N, Nitta A, Kamata T. Incorporation of zolpidem and methoxyphenamine into white hair strands after single administrations: Influence of hair pigmentation on drug incorporation. Forensic Sci Int 2019;301:67-75.
  47. Uematsu T, Sato R, Fujimori O, Nakashima M. Human scalp hair as evidence of individual dosage history of haloperidol: A possible linkage of haloperidol excretion into hair with hair pigment. Arch Dermatol Res 1990;282(2):120-125.
  48. Sato H, Uematsu T, Yamada K, Nakashima M. Chlorpromazine in human scalp hair as an index of dosage history: Comparison with simultaneously measured haloperidol. Eur J Clin Pharmacol 1993;44(5):439-444.
  49. Mizuno A, Uematsu T, Oshima A, Nakamura M, Nakashima M. Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior. Ther Drug Monit 1993;15(2):99-104.
  50. Rothe M, Pragst F, Thor S, Hunger J. Effect of pigmentation on the drug deposition in hair of grey-haired subjects. Forensic Sci Int 1997;84(1-3):53-60.
  51. Pötsch L, Skopp G, Moeller MR. Influence of pigmentation on the codeine content of hair fibers in guinea pigs. J Forensic Sci 1997;42(6):1095-1098.
  52. Nakahara Y, Takahashi K, Kikura R. Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair. Biol Pharm Bull 1995;18(9):1223-1227.
  53. Gaillard Y, Pépin G. Testing hair for pharmaceuticals. J Chromatogr B Biomed Sci Appl 1999;733(1-2):231-246.
  54. Henderson GL. Mechanisms of drug incorporation into hair. Forensic Sci Int 1993;63(1-3):19-29.
  55. Tzatzarakis MN, Alegakis AK, Kavvalakis MP. Comparative evaluation of drug deposition in hair samples collected from different anatomical body sites. J Anal Toxicol 2017;41(3):214-223.
  56. Montesano C, Johansen SS, Nielsen MK. Validation of a method for the targeted analysis of 96 drugs in hair by UPLC-MS/MS. J Pharm Biomed Anal 2014;88:295-306.
  57. Mazzarino M, Perretti I, Stacchini C, Comunità F, de la Torre X, Botrè F. UPLC-MS-based procedures to detect prolyl-hydroxylase inhibitors of HIF in urine. J Anal Toxicol 2021;45(2):184-194.
  58. Association of Official Racing Chemists. AORC guidelines for the minimum criteria for identification by chromatography and mass spectrometry. http://www.aorc-online.org/documents/aorc-ms-criteria-modified-23-aug-16/. Accessed September 28, 2021.
  59. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001;81(1):449-494.
  60. Salim S, Kamalasanan K. Controlled drug delivery for alopecia: A review. J Control Release 2020;325:84-99.

Citations

This article has been cited 1 times.
  1. Ishii H, Shibuya M, Kusano K, Sone Y, Kamiya T, Wakuno A, Ito H, Miyata K, Sato F, Kuroda T, Yamada M, Leung GN. Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control.. Curr Drug Metab 2022;23(10):850-865.
    doi: 10.2174/1389200223666220825093945pubmed: 36017833google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.